Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Debruyne

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
The Journal of Urology|January 13, 2006
Post-void residual urine volume is not a good predictor of the need for invasive therapy among patients with benign prostatic hyperplasiaC A Mochtar, L A L M Kiemeney, M M van Riemsdijk, et al.
European Urology|December 4, 2003
Prostate-specific antigen as an estimator of prostate volume in the management of patients with symptomatic benign prostatic hyperplasiaC A Mochtar, L A L M Kiemeney, M M van Riemsdijk, et al.
Urology|February 15, 2005
Prognostic role of prostate-specific antigen and prostate volume for the risk of invasive therapy in patients with benign prostatic hyperplasia initially managed with alpha1-blockers and watchful waitingC A Mochtar, L A L M Kiemeney, M P Laguna, et al.
Neurourology and Urodynamics|April 23, 2003
Percutaneous tibial nerve stimulation in the treatment of overactive bladder: urodynamic dataVera Vandoninck, Michael R van Balken, Enrico Finazzi Agrò, et al.
Urology|March 18, 2003
Posterior tibial nerve stimulation in the treatment of idiopathic nonobstructive voiding dysfunctionVera Vandoninck, Michael R van Balken, Enrico Finazzi Agro, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Correlation of transrectal ultrasound, computer analysis of transrectal ultrasound and histopathology of radical prostatectomy specimenH P Beerlage, R G Aarnink, E Th Ruijter, et al.
Neurourology and Urodynamics|December 13, 2002
Posterior tibial nerve stimulation in the treatment of urge incontinenceVera Vandoninck, Michael R Van Balken, E Finazzi Agró, et al.
World Journal of Urology|June 24, 2003
A randomized study comparing epirubicin in a 4-weekly versus a weekly intravenous regimen in patients with metastatic, hormone resistant, prostatic carcinoma: effects on health related quality of lifeG van Andel, P Fernandez de Moral, C T M Caris, et al.
Urology|July 22, 1998
Liarozole--a novel treatment approach for advanced prostate cancer: results of a large randomized trial versus cyproterone acetate. Liarozole Study GroupF J Debruyne, R Murray, Y Fradet, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 20, 2002
Vaccination of patients with metastatic renal cell carcinoma with autologous dendritic cells pulsed with autologous tumor antigens in combination with interleukin-2: a phase 1 studyJeannette C Oosterwijk-Wakka, Dorien M Tiemessen, Ivar Bleumer, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
The Journal of Urology|January 13, 2006
Post-void residual urine volume is not a good predictor of the need for invasive therapy among patients with benign prostatic hyperplasiaC A Mochtar, L A L M Kiemeney, M M van Riemsdijk, et al.
European Urology|December 4, 2003
Prostate-specific antigen as an estimator of prostate volume in the management of patients with symptomatic benign prostatic hyperplasiaC A Mochtar, L A L M Kiemeney, M M van Riemsdijk, et al.
Urology|February 15, 2005
Prognostic role of prostate-specific antigen and prostate volume for the risk of invasive therapy in patients with benign prostatic hyperplasia initially managed with alpha1-blockers and watchful waitingC A Mochtar, L A L M Kiemeney, M P Laguna, et al.
Neurourology and Urodynamics|April 23, 2003
Percutaneous tibial nerve stimulation in the treatment of overactive bladder: urodynamic dataVera Vandoninck, Michael R van Balken, Enrico Finazzi Agrò, et al.
Urology|March 18, 2003
Posterior tibial nerve stimulation in the treatment of idiopathic nonobstructive voiding dysfunctionVera Vandoninck, Michael R van Balken, Enrico Finazzi Agro, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Correlation of transrectal ultrasound, computer analysis of transrectal ultrasound and histopathology of radical prostatectomy specimenH P Beerlage, R G Aarnink, E Th Ruijter, et al.
Neurourology and Urodynamics|December 13, 2002
Posterior tibial nerve stimulation in the treatment of urge incontinenceVera Vandoninck, Michael R Van Balken, E Finazzi Agró, et al.
World Journal of Urology|June 24, 2003
A randomized study comparing epirubicin in a 4-weekly versus a weekly intravenous regimen in patients with metastatic, hormone resistant, prostatic carcinoma: effects on health related quality of lifeG van Andel, P Fernandez de Moral, C T M Caris, et al.
Urology|July 22, 1998
Liarozole--a novel treatment approach for advanced prostate cancer: results of a large randomized trial versus cyproterone acetate. Liarozole Study GroupF J Debruyne, R Murray, Y Fradet, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 20, 2002
Vaccination of patients with metastatic renal cell carcinoma with autologous dendritic cells pulsed with autologous tumor antigens in combination with interleukin-2: a phase 1 studyJeannette C Oosterwijk-Wakka, Dorien M Tiemessen, Ivar Bleumer, et al.
Pageof 8